Open access
Open access
Powered by Google Translator Translator

Review: Immune Checkpoint Inhibitors-induced Endocrinopathies in Cancer Patients

25 Feb, 2019 | 00:55h | UTC

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports – Clinical Diabetes and Endocrinology (free)

Related Guidelines: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (free) AND Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (free)


Stay Updated in Your Specialty


No spam, just news.